Skip to main content
OpenTrials
Completed

NCT Number: NCT00625950

Endometriosis Patients Undergoing Quinagolide Treatment

Dopamine agonists, such as quinagolide, are able to act on the VEGFR-2 blocking antibodies, diminishing Vascular Endothelial Growth Factor effect on angiogenesis in human endometriotic lesions.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hyperprolactinemia Brain Diseases Central Nervous System Diseases Endocrine System Diseases Endometriosis Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Female Hyperpituitarism Hypothalamic Diseases Nervous System Diseases Pituitary Diseases Urogenital Diseases

Age range

18 year–37 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

Instituto Valenciano de Infertilidad

Valencia, 46015, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Hyperprolactinemia
  • Unexplained infertility
  • Endometriosis

Treatment and study plan

endometrial biopsy

Procedure

Two routine laparoscopies in period of three months with endometrial biopsy comparative study performed.

Primary outcomes

  1. observation of three month treatment with Quinagolida in endometriosis patients

    Time frame: onset and three months after onset

Sponsors and collaborators

Lead sponsor

Instituto Valenciano de Infertilidad, IVI VALENCIA

Other

Registry information

Official study title

Effect of Treatment With Agonist Dopaminergics on Endometriosic Lesions.

Important dates

Study start
2008
Primary completion
2008
Study completion
2008
First posted
Feb 29, 2008
Registry last updated
Jan 12, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.